Related Experiment Video

Updated: Jul 5, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

Towards a gene therapy clinical trial for epidermolysis bullosa

Stefano Ferrari1, Graziella Pellegrini, Tatsuya Matsui

  • 1Epithelial Stem Cell Research Centre, Veneto Eye Bank Foundation, Ospedale Civile SS Giovanni e Paolo, Sestiere Castello 6777, 30122 Venezia, Italy.

Reviews on Recent Clinical Trials
|May 14, 2008
PubMed

Insights

Gene therapy offers a promising treatment for Epidermolysis Bullosa (EB), a severe skin disorder. Researchers are initiating a clinical trial using genetically corrected skin stem cells to treat Junctional EB.

Area of Science:

  • Dermatology
  • Genetics
  • Regenerative Medicine

Background:

  • Epidermolysis Bullosa (EB) encompasses severe genetic blistering skin disorders caused by impaired keratinocyte adhesion.
  • Current treatments for EB are limited, affecting an estimated 400,000-500,000 individuals globally.
  • Gene therapy presents a potential therapeutic avenue for these inherited conditions.

Purpose of the Study:

  • To evaluate the safety and efficacy of gene therapy for Junctional Epidermolysis Bullosa.
  • To investigate the potential of genetically corrected epidermal stem cells for treating severe skin blistering disorders.
  • To advance therapeutic strategies for inherited skin fragility syndromes.

Main Methods:

  • Utilizing integrating vectors for stable transduction of human epidermal stem cells.
  • Optimizing culturing conditions to maintain epidermal stemness.
  • Employing surgical grafting techniques for large-area skin regeneration.

Main Results:

  • Pre-clinical studies demonstrate stable genetic correction of adhesion defects in EB keratinocytes in vitro and in vivo.
  • Successful long-term correction of adhesion defects in transplanted epidermal stem cells.
  • Significant progress in clinical applications of cultured keratinocytes for skin regeneration.

Conclusions:

  • The combination of optimized stem cell culturing, efficient gene transfer, and advanced grafting techniques supports a novel gene therapy approach.
  • The submission of a Phase I/II clinical trial marks a significant step towards treating Junctional Epidermolysis Bullosa.
  • Gene-corrected epidermal stem cell transplantation holds promise for addressing the unmet medical needs in severe EB.

More Related Videos

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells11:38

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Published on: November 26, 2018

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...